Growing Geriatric Population And Cardiovascular Mortality Rates Propel The Cardiovascular Surgical Devices Market Emerges as a Core Driver of the Cardiovascular Surgery Devices And Equipment Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cardiovascular Surgery Devices And Equipment Market Through 2025?
The market for cardiovascular surgery devices and equipment has seen consistent growth over the past few years. It is projected to increase from $1.76 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 2.7%. Factors such as the rise in cardiovascular diseases, technological innovation, an aging population, and management of chronic diseases have contributed to the growth during the historic period.

What's the Projected Size of the Global Cardiovascular Surgery Devices And Equipment Market by 2029?
The market for cardiovascular surgery devices and equipment is anticipated to experience consistent growth over the next few years, reaching $1.97 billion in 2029 with a compound annual growth rate (CAGR) of 2.2%. The expansion in the forecasted period is ascribed to the advent of minimally invasive surgery, advanced imaging, personalized medicine, and telemedicine including teleconsultations. Other significant trends expected during this period include hybrid operating rooms, transcatheter procedures, artificial intelligence's role in surgery, and remote surgical training.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Top Growth Drivers in the Cardiovascular Surgery Devices And Equipment Industry: What's Accelerating the Market?
The cardiovascular surgical devices market is being propelled by an increasing elderly population and a surge in fatalities linked to cardiovascular illnesses. As per the American Heart Association (AHA), around 43.7 million individuals aged 60 and above in the US have cardiovascular disorders. It's also noted by AHA that cardiac-related deaths tally at 17.3 million annually, a figure projected to exceed 23.6 million globally by 2030. These conditions necessitate a growing number of surgeries, which in turn fuels the market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

Which Emerging Trends Are Transforming the Cardiovascular Surgery Devices And Equipment Market in 2025?
Leading firms are pouring resources into enterprises functioning within the Cardiovascular Surgery Devices and Equipment market, particularly those fixated on developing groundbreaking solutions like CardioVisio for Atrial Fibrillation (AFib). These efforts aim to boost early detection, elevate patient outcomes, and optimize treatment avenues. CardioVisio for Atrial Fibrillation (AFib) is an innovative diagnostic and monitoring tool built to identify and manage AFib, a prevalent form of irregular heart rhythm. For example, in August 2023, GE HealthCare, a medical tech enterprise based in the US, unveiled CardioVisio for Atrial Fibrillation (AFib), a digital clinical decision support apparatus focused on increasing precise care for AFib patients. Launched at the ESC Congress 2023, this state-of-the-art solution amalgamates longitudinal patient data from diverse sources, equipping clinicians with an exhaustive perspective of cardiovascular health. By delivering recommendations founded on AFib guidelines, CardioVisio makes clinical processes more efficient and encourages adherence to superior practices.

What Are the Main Segments in the Cardiovascular Surgery Devices And Equipment Market?
The cardiovascular surgery devices and equipment market covered in this report is segmented -

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research Laboratories

Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp

Which Top Companies are Driving Growth in the Cardiovascular Surgery Devices And Equipment Market?
Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton dic*kinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.

Which Regions Will Dominate the Cardiovascular Surgery Devices And Equipment Market Through 2029?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2024. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2389

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.